| Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology MB Daly, T Pal, MP Berry, SS Buys, P Dickson, SM Domchek, ... Journal of the National Comprehensive Cancer Network 19 (1), 77-102, 2021 | 590 | 2021 |
| NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020: featured updates to the NCCN guidelines MB Daly, R Pilarski, MB Yurgelun, MP Berry, SS Buys, P Dickson, ... Journal of the National Comprehensive Cancer Network 18 (4), 380-391, 2020 | 364 | 2020 |
| Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo S Sinha, K Pal, A Elkhanany, S Dutta, Y Cao, G Mondal, S Iyer, ... International Journal of Cancer 132 (5), 1201-1212, 2013 | 113 | 2013 |
| Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer RA Leon-Ferre, MY Polley, H Liu, JA Gilbert, V Cafourek, DW Hillman, ... Breast cancer research and treatment 167, 89-99, 2018 | 97 | 2018 |
| Clinical correlates of common corneal neovascular diseases: a literature review NS Abdelfattah, M Amgad, AA Zayed, H Salem, AE Elkhanany, H Hussein, ... International journal of ophthalmology 8 (1), 182, 2015 | 91 | 2015 |
| GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways S Bhattacharya, K Pal, AK Sharma, SK Dutta, JS Lau, IK Yan, E Wang, ... PloS one 9 (12), e114409, 2014 | 81 | 2014 |
| Primary and secondary breast angiosarcoma: single center report and a meta-analysis Y Abdou, A Elkhanany, K Attwood, W Ji, K Takabe, M Opyrchal Breast Cancer Research and Treatment 178, 523-533, 2019 | 69 | 2019 |
| Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion S Yao, TYD Cheng, A Elkhanany, L Yan, A Omilian, SI Abrams, S Evans, ... JNCI: Journal of the National Cancer Institute 113 (8), 1036-1043, 2021 | 58 | 2021 |
| Disparities in breast cancer associated with African American identity EM Stringer-Reasor, A Elkhanany, K Khoury, MA Simon, LA Newman American Society of Clinical Oncology Educational Book 41, e29-e46, 2021 | 40 | 2021 |
| Contribution of immune cells to glucocorticoid receptor expression in breast cancer S Gandhi, A Elkhanany, M Oshi, T Dai, M Opyrchal, H Mohammadpour, ... International journal of molecular sciences 21 (13), 4635, 2020 | 35 | 2020 |
| NCCN clinical practice guidelines in oncology (NCCN guidelines®) WJ Gradishar, BO Anderson, J Abraham, R Aft, D Agnese, KH Allison, ... Journal of the National Comprehensive Cancer Network 18 (4), 2020 | 20 | 2020 |
| NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021 MB Daly, T Pal, MP Berry, SS Buys, P Dickson, SM Domchek, ... J. Natl. Compr. Cancer Netw 19, 77-102, 2021 | 18 | 2021 |
| NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Genetic/familial high-risk assessment: breast, ovarian, and pancreatic MB Daly, T Pal, MP Berry, SS Buys, P Dickson, SM Domchek, ... NCCN, Version 2, 2020 | 14 | 2020 |
| The tumor microenvironment in EGFR-driven loco-regional lung adenocarcinoma can predict higher risk of recurrence. M Khalil, A Elkhanany, Y Yang, S Glenn, A Papanicolau-Sengos, ... Journal of Clinical Oncology 37 (15_suppl), 8521-8521, 2019 | 14 | 2019 |
| National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic MB Daly, T Pal, MP Berry, SS Buys, P Dickson, SM Domchek, ... Version, 2022 | 7 | 2022 |
| Cocaine induced pleural and pericardial effusion syndrome S Alqalyoobi, O Vaidya, A Ghanimah, A Elkhanany, A Gohar Case Reports in Pulmonology 2015, 2015 | 7 | 2015 |
| Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer N Vidula, A Lipman, S Kato, C Weipert, K Hesler, G Azzi, A Elkhanany, ... NPJ Breast Cancer 8 (1), 117, 2022 | 6 | 2022 |
| Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2− breast cancer and an ESR1 mutation after disease … S Damodaran, CC O’Sullivan, A Elkhanany, IC Anderson, M Barve, ... Annals of Oncology 34 (12), 1131-1140, 2023 | 4 | 2023 |
| NCCN Guidelines Version 2.2022 Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Vanderbilt-Ingram Cancer Center [Internet]. 2022 SS Buys, P Dickson, SM Domchek, A Elkhanany, S Friedman, M Goggins | 4 | |
| Racial disparity in breast cancer immune microenvironment. A Elkhanany, E Katsuta, K Takabe Journal of Clinical Oncology 36 (15_suppl), 1081-1081, 2018 | 3 | 2018 |
Kazuaki Takabe MD PhD FACSRoswell Park Cancer InstituteVerified email at roswellpark.org
